Wednesday, April 18, 2012
Video: Welcome to ATVB 2012
Steven R. Lentz, MD, PhD, FAHA and Mary McDermott, MD, FAHA welcome attendees to Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions, taking place Apri. 18-21, 2012 in Chicago, Ill.
ATVB 2012 Final Program & Abstracts
|The Role of Obesity and Inflammation in Platelet Function |
Jane E. Freedman, M.D., Boston University School of Medicine, Boston, Mass.
|Plenary Session II: Genomics of ATVB Disorders (1:30 p.m.)|
|Genomics of Platelet Function and Thrombosis |
Willem H. Ouwehand, M.D., Ph.D., FRC.Path., University of Cambridge, Cambridge, UK
|9p21 Variants and CVD |
Kelly A. Frazer, Ph.D., UC San Diego Moores Cancer, San Diego, Calif.
|Concurrent Session II D - Clinical Lipidology: Clinical Aspects of Diabetes, Obesity and Insulin Resistance (3:30 p.m.)|
|Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus? |
Henry N. Ginsberg, M.D., Columbia University College of Physicians and Surgeons, New York, N.Y.
- CVD affects more than 36 percent of U.S. adults and accounts for more thann 30 percent of annual mortality in the United States.
- Lifetime risk for developing CVD at age 40 is two in three for men and one in two for women.
- The occurrence of a validated premature atherosclerotic CVD event in either a parent or a sibling is associated with an estimated twp-fold elevated risk for CVD, independent of other traditional risk factors.
- Parental history of premature CHD is associated with increased burden of subclinical atherosclerosis in the coronary arteries and the abdominal aorta.
- Learn more in Heart Disease & Stroke Statistics: 2012 Update